- Home
- GBLI vs NBP Comparison
GBLI vs NBP Comparison
Compare GBLI & NBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | GBLI | NBP |
|---|---|---|
| Founded | 2016 | 2014 |
| Country | United States | United States |
| Employees | N/A | 32 |
| Industry | Property-Casualty Insurers | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 395.4M | 379.3M |
| IPO Year | 2010 | N/A |
Fundamental Metrics
Financial Performance| Metric | GBLI | NBP |
|---|---|---|
| Price | $28.58 | $2.71 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $9.00 |
| AVG Volume (30 Days) | 1.9K | ★ 919.2K |
| Earning Date | 05-06-2026 | 04-07-2026 |
| Dividend Yield | ★ 4.90% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.75 | N/A |
| Revenue | ★ $450,098,000.00 | N/A |
| Revenue This Year | $14.23 | N/A |
| Revenue Next Year | $9.68 | N/A |
| P/E Ratio | $16.33 | ★ N/A |
| Revenue Growth | ★ 2.02 | N/A |
| 52 Week Low | $25.88 | $2.10 |
| 52 Week High | $34.00 | $5.19 |
Technical Indicators
Market Signals| Indicator | GBLI | NBP |
|---|---|---|
| Relative Strength Index (RSI) | 56.64 | 51.11 |
| Support Level | $28.50 | $2.19 |
| Resistance Level | $28.81 | $3.80 |
| Average True Range (ATR) | 0.44 | 0.20 |
| MACD | 0.13 | 0.06 |
| Stochastic Oscillator | 100.00 | 88.24 |
Price Performance
Historical ComparisonAbout GBLI Global Indemnity Group LLC (DE)
Global Indemnity Group LLC is a United States-based holding company with a diversified portfolio of property and casualty insurance-related entities. Along with its subsidiaries, the company operates in the following reportable segments: Agency and Insurance Services, Belmont Insurance Companies - Core (Belmont Core), and Belmont Insurance Companies - Non-Core (Belmont Non-Core). Maximum revenue is generated from the Belmont Core segment, which offers direct insurance and assumed reinsurance products in the E&S (Excess and Surplus) marketplace. The Agency and Insurance Services segment is focused on sourcing, underwriting, and servicing primary and assumed reinsurance business; and specialized insurance service businesses providing technology, AI-enabled marketplace, and claims services.
About NBP NovaBridge Biosciences American Depositary Shares
NovaBridge Biosciences operates as a biotechnology platform, combining business development and clinical research to identify and advance pharmaceutical assets. It integrates scientific discovery with strategic planning and project management to move therapies from research toward potential patient use. Its pipeline includes Givastomig, VIS-101, Ragistomig and Uliledlimab.